MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2008-1349

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2009

Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.

Montravers Françoise, Kerrou Khaldoun, Nataf Valérie, Huchet Virginie, Lotz Jean-Pierre, Ruszniewski Philippe, Rougier Philippe, Duron Françoise, Bouchard Philippe, Grangé Jean-Didier, Houry Sydney, Talbot Jean-Noël

СтатьяПеревод пока не подготовлен

Аннотация

CONTEXT AND

OBJECTIVES

Fluorodihydroxyphenylalanine-(18F) (FDOPA) positron emission tomography (PET) is a recent imaging modality used to localize endocrine tumors. This study was conducted to evaluate the impact of FDOPA-PET on the management of patients referred for carcinoid or noncarcinoid digestive tumors and the clinical relevance of the treatment decisions based on this examination.

METHODS AND PATIENTS: Between March 2002 and December 2006, 101 FDOPA-PET examinations were performed in 78 adult patients for follow-up of histologically documented carcinoid tumor of the ileum (23 patients) or noncarcinoid digestive tumor (26 patients) or to screen for occult digestive endocrine tumors (29 patients). More than one FDOPA-PET examination was performed in 12 patients. The impact of FDOPA PET was evaluated on a per-patient basis by means of a questionnaire completed by the referring physician, and the relevance of the treatment decision was assessed on the basis of follow-up data.

RESULTS

The survey response rate was 91% (71 of 78). The overall impact rate of FDOPA-PET on patient management was 25% (18 of 71). The greatest impact was observed for carcinoid tumors (50%: 11 of 22) and was clinically relevant in every case, followed by occult endocrine tumors (16%: four of 25), and was clinically relevant in three of the four cases, and noncarcinoid tumors (13%: 3 of 22), clinically relevant in only one case.

CONCLUSION

FDOPA-PET appears to be a major tool for the management of carcinoid tumors with excellent diagnostic performances and induced relevant changes in patient management. FDOPA-PET was less sensitive and less useful for the management of noncarcinoid tumors.

Для цитирования: Montravers Françoise, Kerrou Khaldoun, Nataf Valérie, Huchet Virginie, Lotz Jean-Pierre, Ruszniewski Philippe, Rougier Philippe, Duron Françoise, Bouchard Philippe, Grangé Jean-Didier, Houry Sydney, Talbot Jean-Noël. Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.. The Journal of clinical endocrinology and metabolism. 2009. DOI: 10.1210/jc.2008-1349.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.